NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine

News   Oct 23, 2014

 
NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine
 
 
 

RELATED ARTICLES

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..

READ MORE

Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological Aging

News

The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.

READ MORE

Discovery of Immune Defense Mechanism Could Help Improve Treatments

News

Researchers have identified a previously unknown mechanism by which the responses of key cells of the immune system are regulated. The finding could inform research into improved treatments for allergies or chronic inflammatory diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE